Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEHRNASDAQ:CTKBNASDAQ:LABNASDAQ:SEER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEHRAehr Test Systems$11.32-5.0%$9.11$6.27▼$21.44$337.01M2.241.17 million shs857,965 shsCTKBCytek Biosciences$3.22-4.2%$3.30$2.37▼$7.63$407.84M1.26800,720 shs1.30 million shsLABStandard BioTools$1.05$1.10$0.92▼$2.41$398.81M1.52.09 million shs921,713 shsSEERSeer$2.07-2.8%$2.03$1.56▼$2.63$121.86M1.54331,211 shs184,305 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEHRAehr Test Systems+2.41%+7.78%+28.86%+27.62%-13.94%CTKBCytek Biosciences-2.33%+0.60%+12.75%-20.00%-45.63%LABStandard BioTools-2.78%+6.06%-7.89%-7.89%-54.94%SEERSeer-2.74%-2.29%+10.94%+9.23%+13.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEHRAehr Test Systems3.5865 of 5 stars3.50.00.00.03.22.53.1CTKBCytek Biosciences2.3022 of 5 stars3.12.00.00.02.24.20.0LABStandard BioTools2.6736 of 5 stars3.32.00.00.02.73.30.6SEERSeer2.2861 of 5 stars3.03.00.00.01.92.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEHRAehr Test Systems 3.00Buy$25.00120.85% UpsideCTKBCytek Biosciences 2.20Hold$5.6073.91% UpsideLABStandard BioTools 2.50Moderate Buy$2.50138.10% UpsideSEERSeer 2.00Hold$3.0044.93% UpsideCurrent Analyst Ratings BreakdownLatest SEER, CTKB, LAB, and AEHR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025CTKBCytek BiosciencesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.005/12/2025CTKBCytek BiosciencesThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$3.50 ➝ $3.005/9/2025CTKBCytek BiosciencesTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$4.003/19/2025CTKBCytek BiosciencesStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$6.00 ➝ $6.00(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEHRAehr Test Systems$61.48M5.48$1.19 per share9.54$3.86 per share2.93CTKBCytek Biosciences$197.05M2.07$0.02 per share206.16$2.90 per share1.11LABStandard BioTools$169.69M2.35N/AN/A($1.85) per share-0.57SEERSeer$15.06M8.09N/AN/A$6.17 per share0.34Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEHRAehr Test Systems$33.16M$0.7815.0951.45N/A43.41%21.09%18.08%7/15/2025 (Estimated)CTKBCytek Biosciences-$12.15M-$0.09N/A∞N/A-5.05%-2.58%-2.05%8/5/2025 (Estimated)LABStandard BioTools-$74.66M-$0.35N/AN/AN/A-79.92%-27.05%-15.52%7/30/2025 (Estimated)SEERSeer-$86.28M-$1.41N/AN/AN/A-565.83%-21.96%-19.85%8/6/2025 (Estimated)Latest SEER, CTKB, LAB, and AEHR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025SEERSeer-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million5/8/2025Q1 2025CTKBCytek Biosciences-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEHRAehr Test SystemsN/AN/AN/AN/AN/ACTKBCytek BiosciencesN/AN/AN/AN/AN/ALABStandard BioToolsN/AN/AN/AN/AN/ASEERSeerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEHRAehr Test SystemsN/A7.553.82CTKBCytek BiosciencesN/A6.215.47LABStandard BioToolsN/A3.763.41SEERSeerN/A18.3617.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEHRAehr Test Systems69.69%CTKBCytek Biosciences69.46%LABStandard BioTools53.74%SEERSeer75.20%Insider OwnershipCompanyInsider OwnershipAEHRAehr Test Systems6.20%CTKBCytek Biosciences10.33%LABStandard BioTools23.16%SEERSeer11.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEHRAehr Test Systems9029.77 million27.87 millionOptionableCTKBCytek Biosciences500126.66 million116.45 millionOptionableLABStandard BioTools620379.82 million174.59 millionOptionableSEERSeer16058.87 million50.12 millionOptionableSEER, CTKB, LAB, and AEHR HeadlinesRecent News About These CompaniesWhere To Find The Seer In Tainted Grail: The Fall Of AvalonJune 13 at 8:29 AM | msn.comBright The Seer releases prophecy, sends powerful warning message to Tinubu, watch full videoJune 11 at 5:43 PM | msn.comRare cancer diagnoses surge dramatically among millennials, Gen XJune 11 at 5:42 AM | msn.comThe SEER Group Expands Northwest Presence With Acquisition of Oregon’s Associated Heating & Air ConditioningJune 10 at 5:57 PM | joplinglobe.comKalkine : Top NASDAQ Companies by Market Cap Featuring Seer IncJune 10 at 5:57 PM | kalkinemedia.comBright The Seer releases prophecy, reveals “anointed person to win 2027 presidential election”, watch full videoJune 10 at 5:57 PM | msn.comWhat Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?June 10 at 1:01 PM | zacks.comSeer takes the lead in Miyawaki model forest developmentJune 10 at 12:57 PM | timesofindia.indiatimes.comVerydarkman slams Bright the Seer as she prophecies that Wizkid, Tinubu and Wike should see herJune 9, 2025 | msn.comAl Seer Marine's 'Lucky Gas' VLGC sets sailJune 8, 2025 | wam.aeSurgical Outcomes in OAs With Colorectal CancerJune 8, 2025 | physiciansweekly.comOtto Aviation: Unlocking Aerospace Innovation with Galoraths SEER PlatformJune 4, 2025 | eurekamagazine.co.ukOtto Aviation Standardizes on Galorath's AI-Powered Estimation Platform to Drive Price-to-Win Strategies Across Sustainable Aerospace InitiativesJune 3, 2025 | kxan.comAl Seer Marine targets smaller LPG vessels market with new JVJune 3, 2025 | arabianbusiness.comAl Seer Marine and B International launch JV to fuel LPG growthJune 3, 2025 | logisticsmiddleeast.comAl Seer Marine, B International Logistics launch new shipping JVJune 2, 2025 | tradearabia.comAl Seer teams with trader to form new tanker and LPG carrier companyJune 2, 2025 | tradewindsnews.comSeer Launches Sample Study to Develop AI-Driven Cancer Diagnostics for Young AdultsJune 2, 2025 | msn.comAbu Dhabi's Al Seer Marine sets up tanker JV, secures $57mln ADCB term loanJune 2, 2025 | zawya.comProstate Cancer Surgery Rates Drop in Low-Risk CasesJune 1, 2025 | emjreviews.comSeer, Inc. (NASDAQ:SEER) Stake Raised by Two Sigma Advisers LPJune 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesRKLB Breakout Fails Near Highs: Should Investors Be Concerned?By Ryan Hasson | June 11, 2025View RKLB Breakout Fails Near Highs: Should Investors Be Concerned?5 Stocks Set to Soar This SummerBy Ryan Hasson | June 2, 2025View 5 Stocks Set to Soar This SummerGitLab: Buy It Low While You Still Can—Higher Prices Are ComingBy Thomas Hughes | June 11, 2025View GitLab: Buy It Low While You Still Can—Higher Prices Are ComingRocket Lab Expands Into Payloads: Should You Be Paying Attention?By Ryan Hasson | June 3, 2025View Rocket Lab Expands Into Payloads: Should You Be Paying Attention?Retail Investors Are Betting Big on Rocket Lab—Should You Too?By Ryan Hasson | May 16, 2025View Retail Investors Are Betting Big on Rocket Lab—Should You Too?SEER, CTKB, LAB, and AEHR Company DescriptionsAehr Test Systems NASDAQ:AEHR$11.32 -0.60 (-5.03%) Closing price 04:00 PM EasternExtended Trading$11.25 -0.07 (-0.65%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.Cytek Biosciences NASDAQ:CTKB$3.22 -0.14 (-4.17%) Closing price 04:00 PM EasternExtended Trading$3.22 +0.00 (+0.16%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Standard BioTools NASDAQ:LAB$1.05 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.05 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Seer NASDAQ:SEER$2.07 -0.06 (-2.82%) Closing price 04:00 PM EasternExtended Trading$2.07 0.00 (0.00%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
